Viromed Medical AG (VMED.DE) Stock Analyst Ratings

Europe • Frankfurt Stock Exchange • FRA:VMED • DE000A3MQR65

4.08 EUR
-0.12 (-2.86%)
Last: Jan 14, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to VMED.DE. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 10.2. This target is 150% above the current price.
  • VMED.DE was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about VMED.DE.
  • In the previous month the buy percentage consensus was at a similar level.
  • VMED.DE was analyzed by 7 analysts. More opinions would make the average more meaningful.

Related screens

Find peers with buy consensus above 85%
VMED.DE Historical Analyst RatingsVMED.DE Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Price Target & Forecast

Price Low Median Mean High 4.0810.1010.2010.2010.50 - 147.55% 150.00% 150.00% 157.35%

Related screens

Find peers 30% below price target
VMED.DE Current Analyst RatingVMED.DE Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades

Viromed Medical AG / VMED.DE FAQ

What do analysts expect the price target to be for Viromed Medical AG (VMED.DE)?

7 analysts have analysed VMED.DE and the average price target is 10.2 EUR. This implies a price increase of 150% is expected in the next year compared to the current price of 4.08.


How do analysts rate Viromed Medical AG (VMED.DE)?

The consensus rating for Viromed Medical AG (VMED.DE) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.